ARCHIVES

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

This article is from The Cancer Letter archive.

Vol. 18 No. 14 | April 3, 1992

Download PDF Visit The Full Archive

Related Articles

Senate Subcommittee Okays $1 billion For NCI In FY 1980, Agrees To Block Obey Reprogramming

June 15, 1979

ASCO, NCCS Call For Oncology Center

September 13, 2002

Advisors Approve New Grant Programs In Breast Pre-Malignancy, Lung Inflammation

November 17, 2006

NCI Programs: Contract Awarded For Geographic Information System

May 14, 1999

ASCO Is a Society In Transition, Growth; Major changes over Past Year

May 24, 1996

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

August 4, 1995